HIF1A and cancer: Paolicchi et al. suggested that tumor hypoxia is a major contributor to drug resistance and a predisposing factor for increased CSC formation and metastases.231 Therefore, one promising cancer treatment strategy is to block the proteins related to hypoxia-induced factor (HIF)-1α, EMT, and mitochondria functions, which in turn inhibits the response to hypoxia.